SCHEDULE 13G 0002043812 XXXXXXXX LIVE Common Shares, no par value per share 10/23/2025 0001729214 XORTX Therapeutics Inc. 98420Q306 3710 - 33rd Street NW Calgary A0 T2L 2M1 Rule 13d-1(c) Lincoln Alternative Strategies LLC b DE 572470.00 0.00 572470.00 0.00 572470.00 N 9.9 OO Beneficial ownership percentage is based on 5,784,688 shares of the Issuer's common stock issued and outstanding as of October 23, 2025. XORTX Therapeutics Inc. 3710 - 33rd Street NW, Calgary, A0, T2L 2M1 Lincoln Alternative Strategies LLC 404 Washington Ave., Suite 650, Miami Beach, FL 33139 Delaware Y 572,470 9.9% 572,470 0 572,470 0 Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Lincoln Alternative Strategies LLC /s/ Stephen Temes 10/27/2025